510(k) K944604
K944604 is an FDA 510(k) premarket notification submitted by Beckman-Diagnostic Systems Group for the device "CX AMPHETAMINES REAGENT FOR SYNCHRON CX SYSTEMS". The FDA issued a decision of Substantially Equivalent on Dec 7, 1994. The device falls under product code DKZ (Enzyme Immunoassay, Amphetamine), a Class II device regulated under 21 CFR 862.3100. Beckman-Diagnostic Systems Group has 10 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 7, 1994
- Date Received
- Sep 19, 1994
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Amphetamine
- Device Class
- Class II
- Regulation Number
- 862.3100
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Beckman-Diagnostic Systems Group? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.